AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 276: H98-H106, 1999;
0363-6135/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, G.-R.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, G.-R.
Right arrow Articles by Nattel, S.
Vol. 276, Issue 1, H98-H106, January 1999

Transmembrane ICa contributes to rate-dependent changes of action potentials in human ventricular myocytes

Gui-Rong Li1, Baofeng Yang1, Jianlin Feng1, Ralph F. Bosch1, Michel Carrier2, and Stanley Nattel1,3

Departments of 1 Medicine and 2 Surgery, Montreal Heart Institute and University of Montreal, and 3 Department of Pharmacology, McGill University, Montreal, Quebec, Canada H1T 1C8

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

The mechanism of action potential abbreviation caused by increasing rate in human ventricular myocytes is unknown. The present study was designed to determine the potential role of Ca2+ current (ICa) in the rate-dependent changes in action potential duration (APD) in human ventricular cells. Myocytes isolated from the right ventricle of explanted human hearts were studied at 36°C with whole cell voltage and current-clamp techniques. APD at 90% repolarization decreased by 36 ± 4% when frequency increased from 0.5 to 2 Hz. Equimolar substitution of Mg2+ for Ca2+ significantly decreased rate-dependent changes in APD (to 6 ± 3%, P < 0.01). Peak ICa was decreased by 34 ± 3% from 0.5 to 2 Hz (P < 0.01), and ICa had recovery time constants of 65 ± 12 and 683 ± 39 ms at -80 mV. Action potential clamp demonstrated a decreasing contribution of ICa during the action potential as rate increased. The rate-dependent slow component of the delayed rectifier K+ current (IKs) was not observed in four cells with an increase in frequency from 0.5 to 3.3 Hz, perhaps because the IKs is so small that the increase at a high rate could not be seen. These results suggest that reduction of Ca2+ influx during the action potential accounts for most of the rate-dependent abbreviation of human ventricular APD.

calcium current; ion channels; action potential; electrophysiology; cardiac arrhythmias

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

IT IS WELL KNOWN that the cardiac action potential duration (APD) changes with alterations in frequency and APD is significantly abbreviated at rapid rates (3, 10, 15, 35), but the underlying mechanisms are unclear. In mammalian cardiac tissue, rate-dependent abbreviation of APD at rapid rates has been considered to result from an increase in transmembrane K+ conductance (22) and/or an augmentation of Na+-K+ pump activity (11).

Beeler and Reuter (6) reported that membrane Ca2+ current (ICa) is important for determining the plateau phase of the action potential in guinea pig ventricular myocardial fibers. Hume and Uehara (19) found that amplitude and kinetics of ICa are major determinants of the differences in morphology and duration of the action potential in guinea pig atrial and ventricular myocytes. We also found that ICa plays an important role in determining APD in human atrium (25). Therefore, ICa changes may explain rate-dependent changes in cardiac APD. However, whether ICa contributes to the rate-dependent abbreviation of APD in human ventricle is unknown.

The properties of ICa have been described in cardiac cells isolated from human atria and human ventricles (14, 26, 28, 29). However, ICa was characterized at room temperature in most of these studies. It has been demonstrated that changes in temperature profoundly affect the availability and/or time-dependent properties of ICa (1). Therefore, it is important to evaluate the role of ICa in governing rate-dependent changes in APD in humans at normal physiological temperature.

The present study was designed to determine the relation between rate-dependent changes in APD and changes in ICa in human ventricular myocytes at a physiological temperature (36°C). The action potential-voltage clamp ("action potential clamp") technique was used to analyze the potential contribution of changes in ICa to frequency-dependent changes in APD.

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Myocyte isolation. Right ventricular tissues from explanted hearts were obtained at the time of heart transplantation from patients. All hearts were initially placed in cold (4°C) oxygenated Krebs solution and then transferred to cardioplegic solution for dissection and coronary artery cannulation. A procedure described previously (24) was used to isolate ventricular cells. Briefly, a portion of the free wall of the right ventricle (~2 × 4-5 cm) was removed along with the coronary artery branch irrigating it, with dissection and arterial cannulation completed within 20 min of excision of the heart. The free wall was perfused with oxygenated, nominally Ca2+-free Tyrode solution for 20-30 min, and the solution was then changed to one containing 200-300 U/ml collagenase (CLS II, Worthington Biochemical, Freehold, NJ) for 60-100 min. Myocytes were isolated from the digested tissue and placed in a high-K+ storage solution (24).

Cells were obtained from five hearts. The underlying heart disease was congestive cardiomyopathy in three cases and left heart failure due to aortic valve disease in two cases. Examination of the right ventricle by a cardiac pathologist revealed it to be microscopically normal in two cases, to show mild subendocardial fibrosis in one case, and to show cellular hypertrophy in two cases.

A small aliquot of the solution containing the isolated cells was placed in an open perfusion chamber (1 ml) mounted on the stage of an inverted microscope. Myocytes were allowed to adhere to the bottom of the dish for 5-10 min and then superfused at 2-3 ml/min with Tyrode solution. Experiments were conducted at 36°C with temperature controlled by a Peltier-effect device. Only quiescent rod-shaped cells showing clear cross striations were used.

Solutions and chemicals. Tyrode solution contained (mM) 136 NaCl, 5.4 KCl, 1.0 MgCl2, 2.0 CaCl2, 0.33 NaH2PO4, 10.0 glucose, and 10 HEPES; pH was adjusted to 7.4 with NaOH. For cell dissociation, Ca2+ was omitted. A choline solution containing (mM) 136 choline chloride, 5.4 CsCl, 1.0 MgCl2, 2.0 CaCl2, 0.33 NaH2PO4, 10 glucose, and 10 HEPES was used when ICa was measured directly; pH was adjusted to 7.4 with CsOH. The pipette solution for ICa recording (whole cell voltage-clamp mode) contained (mM) 20 CsCl, 110 cesium aspartate, 1.0 MgCl2, 10 HEPES, 10 EGTA, 0.1 GTP, and 5 Mg2ATP; pH was adjusted to 7.2 with CsOH. The pipette solution for action potential recording (current-clamp mode) contained (mM) 20 KCl, 110 potassium aspartate, 1.0 MgCl2, 10 HEPES, 0.05 EGTA [5 for the slow component of the delayed rectifier K+ current (IKs) recording], 0.1 GTP, 5 Mg2ATP, and 5 sodium phosphocreatine; pH was adjusted to 7.2 with KOH.

Electrophysiology and data analysis. The tight-seal whole cell patch-clamp technique was used. Borosilicate glass electrodes (1.0 mm OD) were pulled with a Brown-Flaming puller (model P-87); tip resistances were 2-3 MOmega when filled with pipette solution. Data were acquired with the use of an Axopatch 200A and/or 1-D amplifier (Axon Instruments, Foster City, CA). Command pulses were generated by a 12-bit digital-to-analog converter controlled by pCLAMP software (Axon Instruments). Recordings were low-pass filtered at 2 kHz and stored on the hard disk of an IBM-compatible computer. Tip potentials were compensated before the pipette touched the cell. After a gigaseal (>10 GOmega ) was obtained, the cell membrane was ruptured by gentle suction to establish the whole cell configuration.

The series resistance (Rs) was electrically compensated to minimize the capacitive surge on the current recording and the voltage drop across the clamped membrane. Rs along the clamp circuit was estimated by dividing the capacitive time constant (obtained by fitting the decay of the capacitive transient) by the calculated membrane capacitance (the time integral of the capacitive response to a 5-mV hyperpolarizing pulse from a holding potential of -60 mV divided by the voltage drop). Membrane capacitance was 179 ± 10 pF (n = 25). To control for differences in cell size, all mean data are expressed as current densities (i.e., normalized to capacitance). Before compensation, the capacitive time constant and Rs averaged 1,314.2 ± 113.9 µs and 8.6 ± 0.5 MOmega , and after compensation corresponding values were 381.3 ± 26.2 µs and 2.0 ± 0.3 MOmega . ICa rarely exceeded 2 nA, and the mean maximum voltage drop across the Rs, therefore, did not exceed 4 mV. Cells with significant leak current were rejected. The liquid junction potentials between the external and pipette solutions were 10-11 mV and were not corrected.

The average length of single human ventricular myocytes was 148.3 ± 8.8 µm (n = 15, range 112-185 µm), and the diameter was 18.5 ± 1.2 µm (range 12-25 µm); the estimated cell surface area was therefore 9.2 ± 0.5 × 10-5 cm2 on the basis of assumed right cylinder geometry. The input resistance (Rin) was determined by using four consecutive 5-mV hyperpolarizing steps from a holding potential of -60 mV, with the resulting change in current used to calculate Rin (16). Mean Rin as estimated in 11 cells was 56.7 ± 5.4 MOmega . The resting space constant (sc) was estimated as follows: sc = <RAD><RCD>(<IT>rR</IT><SUB>m</SUB>/2<IT>R</IT><SUB>i</SUB>)</RCD></RAD>, where r is the cell radius, Rm is the specific membrane resistance, and Ri is intracellular resistivity. Rm was estimated from the product of Rin and surface area, providing a mean value of 5.1 ± 0.2 KOmega · cm2, and Ri was assumed to be 100-200 Omega  · cm (18, 32, 40). The mean values of sc were 1.54 ± 0.22 and 1.09 ± 0.16 mm, which are more than seven times the single cell length. These could be underestimated, since the surface area estimated on the basis of a specific capacitance of 1 µF/cm2 is 17.9 × 10-5 cm2, twice as large as the value above, which indicates that membrane infolding results in a true surface area larger than that of a right cylinder (40).

Cells were current clamped to record action potentials and/or voltage clamped with rectangular steps or individual action potential waveforms at 0.5 Hz with pClamp6. In the action potential clamp experiments, ICa was identified by subtracting currents before and after the substitution of external Ca2+ with equimolar Mg2+, as described by Bouchard et al. (9). Similar results were obtained with use of Cd2+ (200 µM) to suppress ICa, but all the results were with Mg2+ substitution, because Cd2+ can also affect Na+ current (INa).

Nonlinear curve-fitting techniques (Clampfit in pClamp6 or Sigmaplot, Jandel Scientific, San Rafael, CA) based on the Marquardt procedure were used to fit equations to experimental data. Paired and nonpaired Student's t-tests were used as appropriate to evaluate the statistical significance of differences between two group means, and ANOVA was used for multiple groups. P < 0.05 was considered to indicate significance. Group data are expressed as means ± SE.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Relation between changes in APD and ICa. To study the relation between rate-dependent abbreviation of APD and ICa, we recorded action potentials in current-clamp mode at 0.5, 1, and 2 Hz before and after external Ca2+ substitution with equimolar external Mg2+. The resting membrane potentials were between -69 and -73 mV without any artificial current injection. Figure 1A shows action potentials recorded from a representative human ventricular myocyte at frequencies of 0.5, 1, and 2 Hz in the presence of 2 mM external Ca2+ (control). APD decreased as stimulus rates increased. The average changes in APD at 50 and 90% repolarization (APD50 and APD90) are shown in Fig. 1B. APD50 and APD90 decreased from 325 ± 23 and 439 ± 37 ms, respectively, at a frequency of 0.5 Hz to 181 ± 12 and 281 ± 21 ms, respectively, at 2 Hz (P < 0.01, n = 18). The mean rate-dependent reductions were 44 ± 4% for APD50 and 36 ± 4% for APD90. Replacement of external Ca2+ by 2 mM external Mg2+ greatly attenuated APD adaptation to rate. Figure 1C shows APD recordings from the same cell and at the same frequencies as in Fig. 1A but in the presence of 2 mM external Mg2+ to replace external Ca2+. APD was substantially reduced and showed little alteration with changes in rate. As indicated in Fig. 1C, inset, substitution of external Ca2+ with external Mg2+ totally suppressed ICa on depolarization from -40 to 0 mV in the same cell. In eight cells, replacement of external Ca2+ virtually abolished rate-dependent changes in APD, as shown by the mean data in Fig. 1D. The reduction in APD50 and APD90 caused by increasing rate from 0.5 to 2 Hz averaged 5 ± 2 and 6 ± 3%, respectively, which is substantially less (P < 0.01) than under control conditions over the same range of frequencies. On restoration of external Ca2+ concentration to 2 mM, rate-dependent changes in APD50 and APD90 were restored to 39 ± 5 and 33 ± 5% as rate increased from 0.5 to 2 Hz (n = 4).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Rate-dependent changes in action potential duration (APD) and Ca2+ current (ICa). A: increase in rate from 0.5 Hz to 1 and 2 Hz shortened APD from a representative cell. B: increase in rate from 0.5 Hz to 1 and 2 Hz significantly decreased averaged APD at 50 and 90% repolarization (APD50 and APD90) in control cells (n = 18). ** P < 0.01 vs. 0.5 Hz. C: substitution of external Ca2+ with equimolar external Mg2+ (2 mM) decreased APD and attenuated rate-dependent abbreviation of APD by inhibition of ICa; inset: ICa activated by 300-ms step to 0 mV from holding potential (HP) of -40 mV in same cell was suppressed by external Ca2+ replacement. D: averaged APD at various frequencies on substitution of external Ca2+ with external Mg2+ in 8 cells. Values are means ± SE.

Action potential clamp and ICa. To obtain more information about how ICa contributes to rate-dependent abbreviation of APD, we used the action potential waveform to clamp individual cells and to quantify ICa during the action potential at different frequencies. The action potential was acquired from each cell at 0.5 Hz and used as a voltage-clamp waveform in the same cell. External Ca2+-dependent current (ICa) was measured by digital subtraction of the currents before and after substitution of external Ca2+ with equimolar external Mg2+, as described by Bouchard et al. (9). Figure 2 shows representative recordings from a ventricular myocyte. Figure 2A demonstrates the action potential waveform, and Fig. 2B shows currents elicited by the action potential waveform in the presence (control) and absence of 2 mM external Ca2+ (Mg2+). Figure 2C shows the ICa obtained by subtracting currents of Fig. 2B in the absence of external Ca2+ (Mg2+) from those in its presence (control). ICa increased rapidly to a peak and then decreased rapidly to a plateau, which terminated with repolarization.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 2.   Determination of ICa with action potential clamp protocol. A: action potential recorded from a human ventricular myocyte was used to clamp cell. B: ionic current recorded in same cell before and after substitution of external Ca2+ with equimolar external Mg2+. C: subtraction of currents before and after replacement of external Ca2+ shows net ICa during action potential. Zero on current scale refers to zero net membrane current.

Figure 3 displays external Ca2+-dependent charge movement during the action potential at 0.5-2 Hz in a representative human ventricular myocyte. Figure 3A shows the action potential waveform, and Fig. 3B displays current recordings obtained by digital subtraction from control currents (in the presence of 2 mM Ca2+) at 0.5, 1, and 2 Hz of the currents recorded at corresponding frequencies in the presence of 2 mM external Mg2+ (to replace external Ca2+). External Ca2+-dependent ICa magnitude was significantly decreased at 1 and 2 Hz, compared with 0.5 Hz, during the action potential.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Rate-dependent changes in Ca2+ influx during action potential. A: action potential waveform recorded at 0.5 Hz was used as a voltage command waveform. B: ICa during action potential at 0.5, 1, and 2 Hz, which was obtained by subtracting currents before and after substitution of external Ca2+ with equimolar external Mg2+ (2 mM) as in Fig. 2C.

Peak and plateau ICa were evaluated during the action potential at the frequencies tested. Plateau ICa was measured at 150 ms from action potential depolarization. In a total of nine cells, peak and plateau ICa substantially decreased as frequency increased. Peak and plateau ICa densities declined from 5.6 ± 0.5 and 1.7 ± 0.3 pA/pF at 0.5 Hz to 3.7 ± 0.3 and 1.1 ± 0.2 pA/pF at 2 Hz (P < 0.01). The results from action potential clamp support the concept that the rate-dependent abbreviation of APD is related to the reduction of Ca2+ influx during the action potential at higher frequencies.

To further study ICa during the action potential, we applied the action potential waveforms recorded at 0.5 and 2 Hz. Table 1 shows peak and plateau ICa at 150 ms from action potential depolarization with the two action potential templates in a total of five cells. No significant difference was observed in peak ICa density between 0.5- and 2-Hz waveforms, and plateau ICa was significantly smaller in the 2- than in the 0.5-Hz action potential waveform at 0.5 and 2 Hz. Although a similar ratio of 2 to 0.5 Hz for peak and plateau ICa was observed with the two templates, the results indicate the importance of ICa for maintaining action potential.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Peak and plateau ICa (at 150 ms from action potential depolarization) during action potential

Frequency-dependent reduction of ICa. To study why Ca2+ influx decreased during the action potential when the rate increased, conventional step voltage-clamp protocols were used to determine use and frequency dependence of ICa under conditions designed to suppress other currents (K+ replacement by Cs+ in the pipette and extracellular Na+ replacement by choline). Figure 4 shows the use and frequency dependence of ICa under these conditions. ICa was recorded with trains of 15 pulses (300 ms from -80 to +10 mV) at 0.2, 0.5, 1, and 2 Hz (60 s between trains). Figure 4A displays representative current traces from the 1st and 15th pulses at 2 Hz. ICa was clearly smaller during the 15th than during the 1st pulse, and time-dependent inactivation of ICa appeared faster at the 15th than that at the 1st pulse. Figure 4B shows changes in ICa during each beat expressed as a function of the first pulse at each frequency. Statistically significant use dependence was noted at frequencies >0.2 Hz (P < 0.05, 0.01, and 0.01 for 0.5, 1, and 2 Hz, respectively). The use-dependent reductions in ICa resulted in frequency dependence of the current, as shown in Fig. 4C, which illustrates the relation between pulse frequency and steady-state peak ICa, with currents of each frequency normalized to values at 0.2 Hz. ICa was reduced significantly at each frequency, with a reduction of 36 ± 2% at 2 Hz.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Use- and frequency-dependent inactivation of ICa. A: representative current traces from 1st and 15th pulses (300 ms) from -80 to +10 mV at 2 Hz in a human ventricular cell. B: results (means ± SE) normalized to 1st pulse of a train after 60 s at frequencies of 0.2, 0.5, 1, and 2 Hz (n = 11). C: steady-state frequency dependence of ICa. Results (means ± SE) for each cell during 15th pulse at each frequency are normalized to current during 1st pulse (n = 6). * P < 0.05; ** P < 0.01 vs. 0.2 Hz.

Time-dependent reactivation of ICa. The time dependence of ICa reactivation was studied with the paired-pulse protocol illustrated in Fig. 5. Identical 300-ms pulses (P1 and P2) from a holding potential of -80 to +10 mV were delivered every 10 s, with varying P1-P2 intervals. The current during P2 relative to the current during P1 was determined as a function of the P1-P2 reactivation interval (Fig. 5A). The curves in Fig. 5B show nonlinear curve fits to mean data at holding potentials of -80 mV (n = 11) and -60 mV (n = 7). ICa recovery reached 97% and was well fit by a biexponential function with time constants of 65 ± 12 and 638 ± 39 ms for a holding potential of -80 mV and 164 ± 15 and 697 ± 45 ms for a holding potential of -60 mV.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Reactivation of ICa. A: representative recordings obtained with 2 identical pulses [300 ms from HP of -80 to +10 mV, inset], P1 and P2, with varying P1-P2 interval. B: recovery curves for ICa at -80 mV (n = 11) and -60 mV (n = 7) were best fit by a biexponential function. ICa did not completely recover during this interval. Values are means ± SE. I1, current during P1; I2, current during P2.

Current-voltage relation of ICa. Two types of ICa ["T type" (ICa,T) and "L type" (ICa,L)] have been found in cardiac cells from a variety of species (4, 5, 30, 38). To determine whether ICa,T is present in human ventricular cells and contributes to rate-dependent changes in APD, current-voltage (I-V) relations of ICa were determined using 300-ms depolarizing steps every 10 s from holding potentials of -80 and -40 mV. The magnitude of ICa was measured as the difference between the peak inward current and the steady-state current at the end of the depolarizing step. For analyses of average currents, ICa was normalized to cell capacitance to control for variations in cell size.

Figure 6A shows ICa recordings from a representative myocyte at a holding potential of -80 mV in the absence and presence of the L-type Ca2+ channel blocker nifedipine (10 µM). Nifedipine abolished the membrane current, which suggests that the current elicited by the voltage protocol shown is ICa,L. Figure 6B shows mean ICa density-voltage relations. ICa density was significantly less at -40 mV (n = 10) than at -80 mV (n = 12) over a broad range of test potentials. Maximum current density was obtained at the same voltage (+10 mV) at each holding potential. No evidence for ICa,T, in terms of a discrete component that activates and inactivates at more negative voltages (4, 5, 30, 31), was observed in any cell.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   Current-voltage (I-V) relations of ICa. A: representative ICa recordings obtained from a human ventricular cell on 300-ms depolarizations at 0.2 Hz (inset) from HP of -80 mV in absence (control) and presence of 10 µM nifedipine (Nif). B: I-V relations of ICa expressed in terms of current density with holding potentials of -40 mV (n = 10) and -80 mV (n = 12). No evidence for T-type ICa was observed. Values are means ± SE. * P < 0.05 vs. -40 mV. TP, test potential.

Voltage-dependent activation and inactivation of ICa. The voltage dependence of ICa activation can be determined from the I-V relation of ICa on the basis of the following formulation: dt = It/[Gx(Vt - Vr)], where dt is the activation variable and It is ICa at a test potential Vt, Gx is the maximum conductance, and Vr is the reversal potential, estimated from a linear fit of the terminal portion of the ascending limb of the I-V relation of ICa. We used this equation to calculate the ICa activation variable from the I-V relation at a holding potential of -80 mV (Fig. 6B). Values of dt were normalized to the maximum value in each cell to obtain the activation variable d.

The voltage protocol and representative recordings used to assess ICa inactivation are illustrated in Fig. 7A. Prepulses of 400-ms duration were applied to conditioning potentials between -100 and +60 mV, and then ICa was recorded during a 300-ms test pulse to +10 mV. The inactivation variable (f) was determined as ICa at a given prepulse potential divided by the maximum ICa in the absence of a prepulse.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   Voltage-dependent activation and inactivation of ICa. A: representative current recordings used to determine voltage dependence of ICa inactivation. Cell was depolarized by 400-ms prepulses from HP of -80 mV to between -100 and 0 mV and back to -80 mV for 5 ms, then subjected to a 300-ms test pulse to +10 mV. B: mean voltage-dependent activation and inactivation relations for ICa. Inactivation was assessed with protocol shown in A. Data were fit to Boltzmann relations for activation and inactivation as follows: d = 1/{1 + exp[(V0.5 - V)/K]} and f = 1/{1 + exp[(V - V0.5)/K]} + R, respectively, where V is membrane potential, V0.5 is membrane potential for half-maximal activation or inactivation, K is a slope factor, and R is a term to characterize degree of incomplete inactivation (see RESULTS) at positive voltages. Values of d and f were calculated as described in RESULTS.

Figure 7B shows the results obtained from the analyses of voltage-dependent activation and inactivation described above. Mean data are shown by the symbols, and the curves shown are best-fit Boltzmann distributions. The half-activation voltage (V0.5) averaged -4.8 ± 0.9 mV (n = 10), and the slope factor was 6.2 ± 1.1 mV. Inactivation reached a maximum at +10 mV and was incomplete. At more positive voltages, the extent of inactivation decreased. The inactivation curve was nonmonotonic or "U shaped," compatible with an important Ca2+-dependent component to inactivation previously seen in human atrial cells (12, 25), and could be fit by a Boltzmann relation with the following equation (33, 34): f = 1/{1 + exp[(V - V0.5)/K]} + R, where V0.5 is the estimated half-maximum inactivation voltage, V is prepulse potential, K is the slope factor, and R characterizes the degree of incomplete inactivation (R = 0.18/{1 + exp[(43 - V)/K]}), providing the curve shown in Fig. 7B. V0.5 averaged -28.5 ± 2.8 mV (n = 7), and K averaged 7.8 ± 1.4 mV.

Rate-dependent IKs. Because a rate-dependent increase in IKs is believed to contribute to the shortening of APD at high rates in guinea pig ventricular myocytes (20), we determined a possible effect of changing depolarization rates on IKs in human ventricular cells. IKs was examined by a 2-s ramp protocol from -50 to +40 mV after a train (0.5 or 3.33 Hz) of 30 step voltage pulses (500-ms; Fig. 8A). The experiment was performed with an external solution that was free of Na+ and K+ in the presence of 5 µM E-4031 [to block the rapid component of the delayed rectifier K+ current (IKr)], 5 mM 4-aminopyridine [to block transient outward K+ current (Ito1)], and 200 µM Cd2+ (to block ICa). Figure 8B shows the ramp-activated IKs with small tail current superimposed at 0.5 and 3.33 Hz in a representative human ventricular cell. Similar results were observed in a total of four cells. No significant difference in IKs or tail current was observed, perhaps because IKs is so small that the rate-dependent change in human ventricular cells could not be seen.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 8.   Rate-dependent slow component of delayed rectifier K+ current (IKs). A: voltage protocol used to determine rate-dependent IKs and tail current. B: IKs and tail current activated by a ramp protocol superimposed at 0.5 and 3.33 Hz in a representative human ventricular cell. Experiment was conducted with a K+- and Na+-free external solution in presence 5 µM E-4031, 5 mM 4-aminopyridine, and 200 µM Cd2+. Similar results were obtained in a total of 4 cells.

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

We have demonstrated that rate-dependent abbreviation of APD in human ventricular myocytes is closely related to changes in Ca2+ influx during the action potential caused by frequency-dependent reduction of ICa due, at least in part, to incomplete time-dependent recovery at higher frequencies.

Comparison with previously published studies of mechanisms for rate-dependent changes of APD in cardiac cells. Rate-dependent abbreviation in cardiac APD has been considered to be related to an increase in transmembrane K+ conductance (22) and/or an increase in Na+-K+ pump activity (11) on the basis of the observation that extracellular K+ was elevated with a parallel increase in frequency (21, 22). Transient outward K+ current (Ito) has been described in human ventricular cells (8, 23, 41); however, its property of rate-dependent reduction does not account for the increase in extracellular K+ or for rate-dependent reduction in APD. Inward rectifier background current (IK1) has been reported to show a rate-dependent decrease in guinea pig ventricular cells that is dependent on the presence of ICa (13), but a decrease of the outward current would not account for rate-dependent abbreviation of APD.

IKs has been reported to show a rate-dependent increase in guinea pig ventricular cells and to contribute to APD abbreviation in that species (20). IKr and IKs have been described in human ventricular cells (24); however, IKs is much smaller in human than in guinea pig ventricular cells. With the use of a ramp protocol, a clear rate-dependent increase in IKs was not observed in human ventricular cells with an increase in frequency from 0.5 to 3.3 Hz (Fig. 8), perhaps because the IKs is so small that the increase at a high rate could not be seen. The small IKs in human ventricular cells we reported previously (24) and recorded in this study may be due to an artifact of the cell isolation procedure and/or the reduced IKs expression in myocytes from failing hearts (but not in normal myocytes).

The present study reveals a close relation between the rate-dependent abbreviation of APD and reduction of Ca2+ influx during the action potential. Earlier studies demonstrate that ICa is very important for determining the plateau phase of cardiac action potential (6), and ICa blockade dramatically shortens cardiac APD (19), whereas ICa increases induced by beta -adrenergic stimulation (25, 39) and Ca2+ channel agonists (39) prolong APD in myocardium, supporting the findings of the present study.

Comparison with previously published studies of ICa in human cardiac cells. Several groups have described the properties of ICa in human cardiac cells (14, 26, 28, 29). Our study differs from these in that we determined Ca2+ influx during the action potential and recorded ICa at body temperature (all previous studies in human ventricular myocytes have been performed at room temperature), characterized recovery and frequency-dependent properties in detail (not reported in previous work), and evaluated the role of ICa in human ventricular action potential behavior (not previously performed). Previous studies have not examined the presence and amplitude of ICa,T in the human ventricle. In the present study we did not find evidence for ICa,T in human ventricular myocytes.

We found that ICa recovery from steady-state inactivation is biexponential, with time constants of 65 and 683 ms at -80 mV and 164 and 697 ms at -60 mV, which indicates that slight membrane depolarization may slow ICa recovery. We also found that ICa shows significant steady-state inactivation at 1 Hz. These findings imply that ICa is partially inactivated at normal heart rates (70 beats/min) and that physiological increases in heart rate are likely to cause further ICa inactivation.

The time dependence of ICa reactivation in ventricular cells is different from our previous findings in human atrial myocytes, in which ICa reactivation is monoexponential at -80 mV, with a time constant of 56 ms. Correspondingly, the frequency-dependent decrease in ICa at -80 mV was more important in ventricular cells (35% reduction at 2 Hz) than in human atrial cells (10% reduction at 2 Hz) (25). Therefore, changes in ICa would contribute more to rate-dependent abbreviation of APD in ventricular cells than in atrial cells in humans. We were unable to find reports of ICa frequency dependence in human ventricular myocytes with which to compare our findings.

Significance of our observations. A better understanding of the ionic mechanisms governing human ventricular repolarization is important for designing improved antiarrhythmic strategies. The rate-dependent properties of ventricular APD and refractoriness are known to be an important determinant of the occurrence of reentrant cardiac arrhythmias (36). Attuel et al. (2) showed that refractoriness abbreviation with increased rates characterizes patients with vulnerability to atrial reentrant arrhythmias. The present study suggests that frequency-dependent ICa reduction contributes significantly to frequency-dependent ventricular APD abbreviation in humans. There is considerable interest in developing novel antiarrhythmic drugs that act selectively during tachycardia, and a better understanding of the mechanisms of physiological APD adaptation to tachycardia in humans, as developed in the present study, is important for this effort.

The properties of ICa have been well described in animals with the use of conventional rectangular depolarizing clamp steps. Little direct information is available in the literature regarding the ICa contribution to rate-dependent changes in APD. Bouchard et al. (9) employed the action potential clamp technique to determine the effects of APD change on excitation-contraction coupling in rat ventricular myocytes. They evaluated ICa during an action potential by subtracting membrane currents before and after the addition of 100 µM Cd2+ or after the substitution of external Ca2+ with external Mg2+. They quantified <LIM><OP>∫</OP></LIM>ICa in rat ventricular myocytes during action potentials and showed that ICa was inactivated before the action potential terminated in rat ventricular cells (9). In the present study we applied the action potential clamp to examine how much ICa was present during the plateau of the action potential, by subtracting membrane currents before and after the substitution of external Ca2+ with external Mg2+ in human ventricular myocytes, and found considerable inward ICa during the action potential plateau. Tachycardia reduced plateau ICa, accounting for action potential abbreviation. Reduced APD during tachycardia shortens the refractory period and the wavelength and may promote the occurrence of reentrant arrhythmias.

Potential limitations. We studied right ventricular cells from patients with severe left ventricular failure, and the patients were receiving medications including captopril, digoxin, dobutamine, and furosemide. It is likely that medications were washed out in the cell isolation process, but we cannot fully exclude an effect of medication on our results. Although the cells used in this study were from hearts that were assessed by the pathologist to have relatively mild or no changes in the right ventricular myocardium, we cannot exclude the possibility that our results were affected by the presence of heart disease. The small IKs we recorded may be related to the reduced expression during heart disease.

To study the effect of ICa on rate-dependent changes in APD, ICa must be blocked; however, pure Ca2+ channel blockers are not available. The inorganic Ca2+ channel blocker Cd2+ can affect INa, whereas the 1,4-dihydropyridine Ca2+ antagonists may also block Ito (17). We therefore replaced external Ca2+ with equimolar Mg2+ (9). The elimination of ICa may limit Ca2+-induced Ca2+ release from sarcoplasmic reticulum and, therefore, inhibit Na+/Ca2+ exchanger current during the action potential (7). This may also induce action potential shortening, which may cause an overestimation of the direct role of ICa in action potential abbreviation. On the other hand, possible Ca2+-activated currents, such as Ca2+-activated Cl- and K+ currents, are also reduced by the removal of external Ca2+, but the effect would not account for rate-dependent shortening of APD, since Ca2+-activated Cl- and K+ currents are repolarizing currents, which will tend to shorten APD.

In the present study, ICa and ICa kinetics were studied using Na+-free superfusate to prevent contamination by INa. In the absence of extracellular Na+, Ca2+ extrusion via the Na+/Ca2+ exchanger is inhibited and cellular integrity is threatened by progressive Ca2+ overload. Cells were therefore dialyzed with 10 mM EGTA via the pipette solution. However, this may result in strong intracellular Ca2+ buffering, limit ICa inactivation because of sarcoplasmic reticulum Ca2+ release, and slow the rapid phase of inactivation (37). Therefore, we may have underestimated the rate of this process and the extent of physiological frequency-dependent ICa inactivation.

ICa rundown may be problematic when patch-clamp techniques are used. In our experience, cell quality is a major factor determining rundown, and we did not observe important rundown over the course of our experiments. We recorded current amplitude before and after each protocol. If maximum current amplitude decreased by >5% over the course of an experimental protocol, the data were discarded.

At room temperature, upregulation of ICa has been reported at high frequency in atrial myocytes from a subgroup of patients (32). We did not find such an increase, perhaps because of differences in experimental protocols and conditions, cell types, and/or patient population.

In conclusion, we have demonstrated that rate-dependent abbreviation of human ventricular APD is largely attributable to rate-dependent changes in ICa. Time-dependent recovery of ICa and its consequent frequency dependence are likely to be significant contributors to the physiological control of human ventricular APD and to be important in controlling the occurrence of ventricular reentrant arrhythmias such as ventricular tachycardia and/or fibrillation.

    ACKNOWLEDGEMENTS

The authors thank Haiying Sun for development of the action potential-clamp technique with pClamp6 and for data analysis and technical assistance and Caroll Boyer for secretarial help.

    FOOTNOTES

This work was supported by the Heart and Stroke Foundation of Quebec, the Fonds de la Recherche en Santé du Québec, the Medical Research Council of Canada, and the Fonds de Recherche de l'Institut de Cardiologie de Montréal. G.-R. Li was a research scholar of the Fonds de la Recherche en Santé du Québec. R. F. Bosch holds a fellowship of the Deutscheforschungsgemeinschaft.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests: G.-R. Li, Dept. of Physiology, Medical College of Virginia, Virginia Commonwealth University, 1101 East Marshall St., PO Box 980551, Richmond, VA 23298-0551.

Received 13 February 1998; accepted in final form 18 September 1998.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Allen, T. J. A. Temperature dependence of macroscopic L-type calcium channel currents in single guinea pig ventricular myocytes. J. Cardiovasc. Electrophysiol. 7: 307-321, 1996[Medline].

2.   Attuel, P., R. R. Childers, B. Cauchemez, J. Poveda, J. Mugica, and P. Coumel. Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. Int. J. Cardiol. 2: 179-197, 1982[Medline].

3.   Attwell, D., I. Cohen, and D. A. Eisner. The effects of heart rate on the action potential of guinea pig and human ventricular muscle. J. Physiol. (Lond.) 313: 439-461, 1981[Abstract/Free Full Text].

4.   Bean, B. P. Two kinds of calcium channels in canine atrial cells. J. Gen. Physiol. 86: 1-30, 1985[Abstract/Free Full Text].

5.   Bean, B. P. Classes of calcium channels in vertebrate cells. Annu. Rev. Physiol. 80: 316-325, 1989.

6.   Beeler, G. W., and H. Reuter. Membrane calcium current in ventricular myocardial fibres. J. Physiol. (Lond.) 207: 191-209, 1970[Abstract/Free Full Text].

7.   Bènardeau, A., S. N. Hatem, C. Rücher-Martin, B. Le Grand, L. Macé, P. Dervanian, J.-J. Mercadier, and E. Coraboeuf. Contribution of Na+/Ca2+ exchange to action potential of human atrial myocytes. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1151-H1161, 1996[Abstract/Free Full Text].

8.   Beuckelmann, D. J., M. Näbauer, and E. Erdmann. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ. Res. 73: 379-385, 1993[Abstract/Free Full Text].

9.   Bouchard, R. A., R. B. Clark, and W. R. Giles. Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes. Action potential voltage-clamp measurements. Circ. Res. 76: 790-801, 1995[Abstract/Free Full Text].

10.   Boyett, M. R., and B. R. Jeewell. A study of the factors responsible for rate-dependent shortening of the action potential in mammalian ventricular muscle. J. Physiol. (Lond.) 285: 359-380, 1978[Abstract/Free Full Text].

11.   Cohen, I. S., R. T. Falk, and R. P. Kline. Membrane currents following activity in canine cardiac Purkinje fibres. Biophys. J. 33: 281-288, 1981[Abstract/Free Full Text].

12.   Cohen, N. M., and W. J. Lederer. Calcium current in single human cardiac myocytes. J. Cardiovasc. Electrophysiol. 4: 422-437, 1993[Medline].

13.   Delmar, M., J. Ibarra, J. Davidenko, P. Lorente, and J. Jalife. Dynamics of the background outward current of single guinea pig ventricular myocytes. Circ. Res. 69: 1316-1326, 1991[Abstract/Free Full Text].

14.   Escande, D., A. Coulombe, J. F. Faivre, and E. Coraboeuf. Characteristics of the time-dependent slow inward current in adult human atrial single myocytes. J. Mol. Cell. Cardiol. 18: 547-551, 1986[Medline].

15.   Gibbs, C. L., and E. A. Johnson. Effect of changes in frequency of stimulation upon rabbit ventricular action potential. Circ. Res. 9: 165-170, 1961[Abstract/Free Full Text].

16.   Giles, W. R., and A. C. G. Van Ginneken. A transient outward current in isolated cells from the crista terminalis of rabbit heart. J. Physiol. (Lond.) 368: 243-264, 1985[Abstract/Free Full Text].

17.   Gotoh, Y., Y. Imaizumi, M. Watanabe, E. F. Shibata, R. B. Clark, and W. R. Giles. Inhibition of transient outward K+ current by DHP Ca2+ antagonists and agonists in rabbit cardiac myocytes. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H1737-H1742, 1991[Abstract/Free Full Text].

18.   Hume, J. R., and W. Giles. Active and passive electrical properties of single bullfrog atrial cells. J. Gen. Physiol. 78: 19-42, 1981[Abstract/Free Full Text].

19.   Hume, J. R., and A. Uehara. Ionic basis of the different action potential configurations of single guinea-pig atrial and ventricular myocytes. J. Physiol. (Lond.) 368: 525-544, 1985[Abstract/Free Full Text].

20.   Jurkiewicz, N. K., and M. C. Sanguinetti. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Circ. Res. 72: 75-83, 1993[Abstract/Free Full Text].

21.   Kline, R. P., I. Cohen, R. Falk, and J. Kupersmith. Activity-dependent extracellular K+ fluctuations in canine Purkinje fibres. Nature 286: 68-71, 1980[Medline].

22.   Kunze, D. L. Rate-dependent changes in extracellular potassium in the rabbit atrium. Circ. Res. 41: 122-127, 1977[Abstract/Free Full Text].

23.   Li, G. R., J. Feng, L. Yue, and M. Carrier. Transmural heterogeneity of action potentials and Ito in myocytes isolated from the human right ventricle. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H369-H377, 1998[Abstract/Free Full Text].

24.   Li, G. R., J. Feng, L. Yue, M. Carrier, and S. Nattel. Evidence for two components of delayed rectifier K+ currents in human ventricular myocytes. Circ. Res. 78: 689-696, 1996[Abstract/Free Full Text].

25.   Li, G. R., and S. Nattel. Properties of human atrial ICa at physiologic temperatures and relevance to action potential. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H227-H235, 1997[Abstract/Free Full Text].

26.   Mewes, T., and U. Ravens. L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium. J. Mol. Cell. Cardiol. 26: 1307-1320, 1994[Medline].

27.   Näbauer, M., D. J. Beuckelmann, P. Überfuhr, and G. Steinbeck. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 93: 168-177, 1996[Abstract/Free Full Text].

28.   Ouadid, H., B. Albat, and J. Nargeot. Calcium currents in diseased human cardiac cells. J. Cardiovasc. Pharmacol. 25: 282-291, 1995[Medline].

29.   Ouadid, H., J. Seguin, S. Richard, P. A. Chaptal, and J. Nargeot. Properties and modulation of Ca channels in adult human atrial cells. J. Mol. Cell. Cardiol. 23: 41-54, 1991[Medline].

30.   Pelzer, D., S. Pelzer, and T. F. McDonald. Calcium channels in heart. In: The Heart and Cardiovascular System, edited by H. A. Fozzard, E. Haber, B. B. Jennings, A. M. Katz, and H. E. Morgan. New York: Raven, 1991, p. 1049-1089.

31.   Piot, C., S. Lemaire, B. Albat, J. Seguin, J. Nargeot, and S. Richard. High frequency-induced upregulation of human cardiac calcium currents. Circulation 93: 120-128, 1996[Abstract/Free Full Text].

32.   Pressler, M. L. Passive electrical properties of cardiac tissue. In: Cardiac Electrophysiology. From Cell to Bedside, edited by D. P. Zipes, and J. Jalife. Philadelphia, PA: Saunders, 1990, p. 108-121.

33.   Qu, Y., D. L. Campell, and H. C. Strauss. Modulation of L-type Ca2+ current by extracellular ATP in ferret isolated right ventricular myocytes. J. Physiol. (Lond.) 471: 295-317, 1993[Abstract/Free Full Text].

34.   Rasmusson, R. L., J. W. Clark, W. R. Giles, K. Robinson, R. B. Clark, E. F. Shibata, and D. L. Campell. A mathematical model of electrophysiological activity in a bullfrog atrial cell. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H370-H389, 1990[Abstract/Free Full Text].

35.   Reiter, M., and F. J. Stickel. The influence of the frequency of contraction on the action potential of the guinea pig papillary muscle. Naunyn Schmiedebergs Arch. Pharmacol. 260: 342-365, 1968.

36.   Smith, J. M., D. T. Kaplan, and R. J. Cohen. The physics of reentry and fibrillation. In: Cardiac Electrophysiology. From Cell to Bedside, edited by D. P. Zipes, and J. Jalife. Philadelphia, PA: Saunders, 1990, p. 215-223.

37.   Sun, H., N. Leblanc, and S. Nattel. Mechanisms of inactivation of L-type calcium channels in human atrial myocytes. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H1625-H1635, 1997[Abstract/Free Full Text].

38.   Tseng, G. N., and P. A. Boyden. Multiple types of Ca2+ currents in single canine Purkinje cells. Circ. Res. 65: 1735-1750, 1989[Abstract/Free Full Text].

39.   Tsien, R. W., B. P. Bean, P. Hess, J. B. Lansman, B. Nilius, and M. C. Nowycky. Mechanisms of calcium channel modulation by beta -adrenergic agents and dihydropyridine calcium agonists. J. Mol. Cell. Cardiol. 18: 691-710, 1986[Medline].

40.   Wang, Z., B. Fermini, and S. Nattel. Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. Circ. Res. 73: 1061-1076, 1993[Abstract/Free Full Text].

41.   Wettwer, E., G. J. Amos, H. Posival, and U. Ravens. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ. Res. 75: 473-482, 1994[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 276(1):H98-H106
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society



This article has been cited by other articles:


Home page
J. Physiol.Home page
K. M. Dibb, D. A. Eisner, and A. W. Trafford
Regulation of systolic [Ca2+]i and cellular Ca2+ flux balance in rat ventricular myocytes by SR Ca2+, L-type Ca2+ current and diastolic [Ca2+]i
J. Physiol., December 1, 2007; 585(2): 579 - 592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-H. Zhang, G.-R. Li, and J.-P. Bourreau
The effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathway
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2888 - H2893.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Altamirano and D. M. Bers
Effect of intracellular Ca2+ and action potential duration on L-type Ca2+ channel inactivation and recovery from inactivation in rabbit cardiac myocytes
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H563 - H573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. H. W. J. ten Tusscher and A. V. Panfilov
Alternans and spiral breakup in a human ventricular tissue model
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1088 - H1100.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. R Valverde, M. O Biagetti, G. R Bertran, P. D Arini, H. Bidoggia, and R. A Quinteiro
Developmental changes of cardiac repolarization in rabbits: Implications for the role of sex hormones
Cardiovasc Res, March 1, 2003; 57(3): 625 - 631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Chiello Tracy, C. Cabo, J. Coromilas, J. Kurokawa, R. S. Kass, and A. L. Wit
Electrophysiological consequences of human IKs channel expression in adult murine heart
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H168 - H175.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
J. L. Greenstein and R. L. Winslow
An Integrative Model of the Cardiac Ventricular Myocyte Incorporating Local Control of Ca2+ Release
Biophys. J., December 1, 2002; 83(6): 2918 - 2945.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S.-J. Kim, R. K. Kudej, A. Yatani, Y.-K. Kim, G. Takagi, R. Honda, D. A. Colantonio, J. E. Van Eyk, D. E. Vatner, R. L. Rasmusson, et al.
A Novel Mechanism for Myocardial Stunning Involving Impaired Ca2+ Handling
Circ. Res., October 26, 2001; 89(9): 831 - 837.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow</